Acne Tarda: Prevalence, Endocrine Correlation, Therapeutic Approaches.
Rotshtein, Sofia Sarah |
Recenzentas / Reviewer | |
Komisijos pirmininkas / Committee Chairman | |
Komisijos narys / Committee Member | |
Komisijos narys / Committee Member | |
Komisijos narys / Committee Member | |
Komisijos narys / Committee Member |
Introduction: The aim of the study was to conduct a systematic review of prevalence, therapeutic approaches, and endocrine correlation of acne tarda. Objectives of the study: 1. To investigate the prevalence of acne tarda. 2. To evaluate therapeutic approaches for late onset acne. 3. To investigate potential correlation between acne tarda and endocrine disorders.
Methodology: A total of 600 studies were identified by searching the NCBI, PubMed and UpToDate databases. Inclusion and exclusion criteria were applied, with a total of 69 articles included.
Results: Conclusions: Acne tarda is a prevalent dermatological condition with a higher prevalence in women and individuals with darker skin tones. Hormonal imbalances related to androgens play a significant role in the condition's pathogenesis, and endocrine disorders such as PCOS are commonly associated with acne tarda. Management of acne tarda requires tailored treatment strategies based on the severity of the condition. Topical retinoids are recommended for mild acne, while a systemic approach is necessary for moderate to severe cases. Hormonal therapies and spironolactone have shown high efficacy in treating adult female acne. Isotretinoin remains a crucial option for severe nodular cystic acne. Maintenance therapy, including the use of topical retinoids and azelaic acid, plays a vital role in preventing acne relapse.
Šiame tyrime buvo peržiūrėtas acne tarda paplitimas, gydymo metodai ir endokrininė sąsaja. Buvo analizuoti 600 tyrimai, įskaitant 69 straipsnius. Acne tarda yra dažna moterų ir tamsesnių odos atspalvių asmenų problema, kuriai svarbų vaidmenį vaidina hormoniniai disbalansai. Gydymo strategijos turėtų būti pritaikytos pagal ligos sunkumą, pradedant nuo vietinių retinoidų lengvoms formoms ir pereinant prie sisteminio gydymo vidutinio ir sunkaus laipsnio spuogams. Hormoninis gydymas, spironolaktonas ir izotretinoinas yra veiksmingi gydymo metodai. Nuolatinis gydymas naudojant vietinius retinoidus ir azelio rūgštį yra esminis spuogų pasikartojimo prevencijos veiksnys.